Loading comparison data...
Medical Disclaimer: This site provides informational comparisons only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before making medication decisions.
Compare ABROCITINIB (CIBINQO) and RUXOLITINIB (OPZELURA) — clinical data, side effects, and patient experiences.
CIBINQO, Cibinqo · JAK Inhibitor
How it works
12.1 Mechanism of Action CIBINQO is a Janus kinase (JAK) inhibitor. Abrocitinib reversibly inhibits JAK1 by blocking the adenosine triphosphate (ATP) binding site. In a cell-free i...
Approved for
OPZELURA, Jakafi, Opzelura · JAK Inhibitor
How it works
12.1 Mechanism of Action Ruxolitinib, a Janus kinase (JAK) inhibitor, inhibits JAK1 and JAK2 which mediate the signaling of a number of cytokines and growth factors that are import...
Approved for
Estimated frequency (%) based on clinical trial data
Based on 15 Reddit discussions
ABROCITINIB
47%
positive
15 threads
RUXOLITINIB
0%
positive
0 threads
% of discussions mentioning each side effect
15 Reddit threads analysed for ABROCITINIB
Overall Sentiment
Mixed
Comparison Threads
2
Avg Post Score
8 upvotes
Most discussed side effects in community
Threads directly comparing ABROCITINIB to other medications
Would someone please cross post to r/dyshidrosis. (they won't let me post because I am a professional researcher in the field). # Traditional Hand Eczema Treatments May Face Obsolescence Ted Bosworth December 18, 2024 [2]()[55]()Add to Email Alerts NEW YORK, NY — For immediate control of a hand ecz
# Traditional Hand Eczema Treatments May Face Obsolescence Ted Bosworth December 18, 2024 [2]()[55]()Add to Email Alerts NEW YORK, NY — For immediate control of a hand eczema flare, the old soak and smear approach with moisturizers or corticosteroids might live on, but they are moving to the back of
Recently started taking a new drug through a clinical trial called Abrocitinib (Made by Pfizer), it is an oral tablet once a day and from what my doctors have said it is comparable and even slightly more effective for people than Dupixent. I wanted to share my results, I have had severe eczema for 7
I've given a few updates on the trial I'm in for Abrocitinib over the past couple of years - thought I'd round it out now the trial is coming to an end. I think I last posted around the 18 month mark and said I felt the effects were wearing off and some mild eczema had returned. I'm happy to say th
I've had full body eczema since about 18 years old. I can't really remember what my skin was like before then. Managing my eczema has been such a big part of my adult life. But after 2 months on dupixent I feel like my skin has never been as smooth.. or as oily! It's honestly taking my brain a whil
Quick rant here! Because It’s getting annoying and frustrating that they always hype up the new drugs for eczema sufferers for example, the JAK inhibitors, and I’m so happy to read the results but they never want to discuss the adverse side effects. They always want to say it’s mild and that they’re
Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.
No community discussions found for RUXOLITINIB yet.
Both ABROCITINIB and RUXOLITINIB belong to the JAK Inhibitor class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients. ABROCITINIB is administered via Oral, whereas RUXOLITINIB uses Topical. Route of administration can affect onset of action and patient adherence.
ABROCITINIB carries 4 FDA warnings. RUXOLITINIB carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..
This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.